About the Company
Pfizer Inc. ( FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in 2023 revenues), a pneumococcal conjugate vaccine ($6 billion in 2023 revenues), palbociclib ($4 billion in 2023 revenues), and tafamidis ($3 billion in 2023 revenues). In 2023, 46% of the company's revenues came from the United States, 6% came from Japan, and 48% came from other countries.The company ranks 38th on the Fortune 500 and 39th on the Forbes Global 2000.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PFE News
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...
Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers.
Pfizer, Biogen and Wolfspeed are making fresh appearances on the NYSE new lows list as the general stock sell-off continues.
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
Pfizer announced positive results from a pivotal clinical trial evaluating Abrysvo's efficacy against respiratory syncytial ...
Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
Pfizer’s cost cuts that began last year have stretched to the closure of a well-known internal R&D team that focused on ...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put on hold while the ...
Pfizer's latest 'Dear Scientist' video stars a long COVID patient looking for answers
As COVID-19 moves into an endemic phase, though rates of coronavirus infections and hospitalizations continue to fall, cases ...
What’s Going On: Pfizer putting $20 million-plus into local renovations
Maybe the sky isn’t falling after all. Dispelling rumors that Pfizer Inc. is continuing to pull back investments at its ...
Canaan adds $100M-plus, Pfizer vet to guide fresh biotech bets
What’s another $100 million tacked onto a previously raised $850 million? Evidently, for venture firm Canaan Partners, tons. ...
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit
A federal court in Massachusetts has granted Pfizer and BioNTech’s motion to put on hold Moderna’s lawsuit over alleged ...
Pfizer, BioNTech win pause in patent infringement case from rival Moderna
After nearly two years of legal back and forth, Pfizer and its German partner BioNTech have won a brief reprieve in their ...
Pfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here
COVID era, emphasizing innovation, oncology, and AI in drug development for potential growth. Learn more on PFE stock here.
ProSource360 wins opportunity to partner with Pfizer through its Diverse OnDemand Marketplace
ProSource360 announces it has been chosen to participate in Pfizer's Diverse OnDemand pilot program, a procurement-developed ...
Loading the latest forecasts...